Sage Therapeutics, Inc. (SAGE): Price and Financial Metrics

SAGE POWR Grades

• SAGE scores best on the Growth dimension, with a Growth rank ahead of 52.18% of US stocks.
• The strongest trend for SAGE is in Growth, which has been heading up over the past 26 weeks.
• SAGE's current lowest rank is in the Sentiment metric (where it is better than 3.59% of US stocks).

SAGE Stock Summary

• For SAGE, its debt to operating expenses ratio is greater than that reported by just 4.84% of US equities we're observing.
• With a price/sales ratio of 114.5, SAGE THERAPEUTICS INC has a higher such ratio than 97.88% of stocks in our set.
• With a year-over-year growth in debt of -49.39%, SAGE THERAPEUTICS INC's debt growth rate surpasses merely 5.14% of about US stocks.
• Stocks that are quantitatively similar to SAGE, based on their financial statements, market capitalization, and price volatility, are LUMO, TDUP, QSI, PALI, and RYTM.
• SAGE's SEC filings can be seen here. And to visit SAGE THERAPEUTICS INC's official web site, go to www.sagerx.com.

SAGE Valuation Summary

• In comparison to the median Healthcare stock, SAGE's EV/EBIT ratio is 112.33% lower, now standing at -1.8.
• SAGE's price/earnings ratio has moved up 29.1 over the prior 115 months.

Below are key valuation metrics over time for SAGE.

SAGE Growth Metrics

The 3 year revenue growth rate now stands at -93.05%.
• Its year over year net income to common stockholders growth rate is now at -176%.
• The 5 year cash and equivalents growth rate now stands at 38.2%.

SAGE's revenue has moved down $1,003,000 over the prior 34 months.

The table below shows SAGE's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	7.686	-460.036	-532.784
2022-09-30	6.464	-430.605	-510.35
2022-06-30	6.165	-380.566	-503.198
2022-03-31	6.307	-376.896	-484.183
2021-12-31	6.308	-378.182	-457.892
2021-09-30	1,113.852	730.29	641.715

SAGE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SAGE has a Quality Grade of C, ranking ahead of 62.22% of graded US stocks.
• SAGE's asset turnover comes in at 0.544 -- ranking 73rd of 681 Pharmaceutical Products stocks.
• VTGN, SVRA, and SESN are the stocks whose asset turnover ratios are most correlated with SAGE.

The table below shows SAGE's key quality metrics over time.